Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2025 Earnings Call Transcript

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2025 Earnings Call Transcript October 29, 2025

Fulcrum Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.31303 EPS, expectations were $-0.29.

Operator: Good morning, and welcome to the Fulcrum Therapeutics Third Quarter 2025 Financial Results and Business Update Conference Call [Operator Instructions] This call is being webcast live and can be accessed on the Investors section of Fulcrum’s website at www.fulcrumtx.com and is...